Bay Street News, 2024

New nonclinical data strengthen evidence of individual contribution of IO102 and IO103 in controlling tumor growth NEW YORK, March 06, […]

Reported $456.3 million in cash resources as of December 31, 2023, which when combined with certain anticipated regulatory milestone payments […]

Fourth Quarter Net Income Attributable to Cohen & Company Inc. of $4.5 Million, or $2.97 per Diluted Share Fourth Quarter […]

WOODCLIFF LAKE, N.J., March 06, 2024 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) announced results for the fourth quarter […]

REDWOOD CITY, Calif., March 06, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing […]

SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition […]

CERRITOS, Calif., March 06, 2024 (GLOBE NEWSWIRE) — GEN Restaurant Group, Inc. (“GEN” or the “Company”), owner of GEN Korean […]

PHILADELPHIA, PA, March 06, 2024 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality, extreme-value retailer for tweens, […]

Expanded Gross Margin in Fourth Quarter 2023 by 180 bps, compared to Fourth Quarter 2022 Grew Fiscal Year 2023 Net […]

WARSAW, Ind., March 06, 2024 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively […]